COVID 19 vaccine(BlueWillow/Medigen)

N/A

Report date: 2022/03/07 16:38:20

Base Information

Drug NameCOVID 19 vaccine(BlueWillow/Medigen)

Drug Alias NameNanoemulsion adjuvanted intranasal COVID 19 vaccine (BlueWillow Biologics)Intranasal COVID 19 vaccine (BlueWillow Biologics)SARS-CoV-2 intranasal vaccineS-2P-NE-01S-2-PNE-01 +[6]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBluewillow Biologics Inc Medigen Vaccine Biologics Corp

China Registration ClassN/A

Develop Information

Active CompaniesMedigen Vaccine Biologics Corp Bluewillow Biologics Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A